Rizwana F. Sproule, VP Regulatory Affairs at Kite Pharma, Inc. (KITE), sold 9,567 shares at $65.28 ($616K) on 2015-09-15, disclosed to the SEC on 2015-09-17.
Scheduled sale ($616k) by VP Regulatory Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.97 | 4,274 | $273K | 44.4% |
| 2 | $64.66 | 5,165 | $334K | 54.2% |
| 3 | $65.28 | 128 | $8K | 1.4% |
| Total | $64.36 avg | 9,567 | $616K | 100% |
| Filing → |
| KITE | SELL | 2016-01-19 | $531K | — | Filing → |
| KITE | SELL | 2015-12-17 | $610K | — | Filing → |
| KITE | SELL | 2015-11-18 | $748K | — | Filing → |